2025 annual financial data
CytoMed Therapeutics 2025 Operating margin
Direct answer
Operating margin was -1,415.96%.
Operating income was -4,519,770 SGD and net income was -3,916,834 SGD.
Operating cash flow was -3,697,463 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 319,201 SGD
- Operating income
- -4,519,770 SGD
- Net income
- -3,916,834 SGD
- Operating cash flow
- -3,697,463 SGD